Paul Thuluvath
Medical Director, The Institute for Digestive Health & Liver Disease at Mercy Health, UMSOM · Univ of Maryland Sch of Med
Credentials: · · ·
History
PresentThe Institute for Digestive Health & Liver Disease at Mercy Health Center · Univ of Maryland Sch of Med
Present
Present
- 1982–1985
Gastroenterology
- 1979–1982
Internal Medicine
- 1975–1979
Doctor of Medicine
Research
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
New England Journal of Medicine · 2014 · 930 citations
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
JAMA · 2023 · 730 citations
Hepatology · 2015 · 522 citations
- AM
28 papers
- JB
27 papers
- KR
26 papers

25 papers
- GG
24 papers

24 papers

22 papers

22 papers
Grants
- 1998–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $4.6K · Johns Hopkins University
Clinical trials
- 2020–2028
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Principal investigator · Recruiting · Phase 4
Mercy Medical Center
- 2016–2018
Principal investigator · Terminated · Phase 3
Vital Therapies, Inc.
- 2007–2008
Principal investigator · Withdrawn
Johns Hopkins University
- 2006–2008
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
Principal investigator · Completed · Phase 3
Debiovision


